We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Papers
61,005 resultsShowing papers similar to Microplastics and Cardiovascular Disease: Should Clinicians Be Paying Attention?
ClearMicroplastics. a New Risk Factor for Atherosclerotic Cardiovascular Disease
This paper reviews emerging evidence linking microplastic exposure to atherosclerotic cardiovascular disease, noting that MPs have been detected in arterial plaques and human tissues and may contribute to cardiovascular risk through inflammation, oxidative stress, and endothelial disruption.
Micro and Nano-plastic particles: What are they and do they effect cardiovascular health?
This review examines the cardiovascular health effects of micro- and nanoplastics, summarizing evidence that these particles have been detected in human tissues including arterial plaques and may promote endothelial dysfunction and inflammation. The authors call for further clinical and epidemiological research into cardiac risk.
Impact of microplastics and nanoplastics on cardiovascular health
This review examines the emerging evidence on how microplastics and nanoplastics may affect cardiovascular health. The study discusses clinical evidence suggesting that these particles can accumulate in the cardiovascular system and highlights possible molecular mechanisms including inflammation and oxidative stress, while noting that current evidence linking microplastics to cardiovascular disease remains largely correlative.
Microplastics: A Modifiable Cardiac Risk Factor
This review examines the emerging evidence linking microplastic exposure to cardiovascular disease risk factors, including oxidative stress, inflammation, endothelial dysfunction, and thrombosis. The study highlights that micro- and nanoplastics have been identified in coronary artery plaque, suggesting that microplastic exposure may represent a modifiable but currently underrecognized cardiac risk factor.
Evidence, Mechanisms, and Clinical Implications of Microplastics and Nanoplastics As Emerging Cardiovascular Risk Factors: A Narrative Review
This review examines growing evidence that micro- and nanoplastics may contribute to cardiovascular health risks, with researchers having found these particles in human artery plaques and blood clots. Evidence indicates that the particles can enter the bloodstream, trigger inflammation, damage blood vessel walls, and potentially increase the risk of heart attacks and strokes. While the evidence is not yet conclusive, the study highlights an emerging area of concern that warrants further investigation into how everyday plastic exposure may affect heart and blood vessel health.
Relationship between microplastics and cardiovascular risk factors
This review examines the emerging evidence linking microplastic exposure to cardiovascular risk factors, including endothelial dysfunction, oxidative stress, and inflammation, which are early indicators of heart disease. The authors conclude that microplastics represent a newly recognized environmental cardiovascular risk factor warranting further clinical research.
Micro-nanoplastics and cardiovascular diseases: evidence and perspectives
Growing evidence suggests that micro- and nanoplastic particles may be a previously unrecognized risk factor for heart disease, as they have been detected in atherosclerotic plaques, heart tissue, and blood clots in humans. Lab studies show these particles can trigger oxidative stress, promote blood clotting, and cause inflammation in blood vessel cells, and their presence in artery plaques has been linked to higher rates of cardiovascular events.
Cardiotoxicity of Microplastics: An Emerging Cardiovascular Risk Factor
This review examines emerging evidence that microplastics may pose risks to cardiovascular health, summarizing findings from laboratory and animal studies. Researchers found that microplastic exposure has been linked to inflammation, oxidative stress, and disrupted heart function in experimental settings. Given that cardiovascular disease is already the leading cause of death globally, the study suggests that microplastics as a potential contributing factor warrant urgent further investigation.
Micro- and nanoplastics: A new cardiovascular risk factor?
This review examines the growing evidence that micro- and nanoplastics may pose risks to the heart and blood vessels. Studies in animals and cell cultures show that these tiny plastic particles can enter the bloodstream, trigger inflammation, promote blood clotting, and damage blood vessel walls. While human data is still limited, the review suggests that micro- and nanoplastic exposure should be considered a potential new risk factor for cardiovascular disease.
Microplastics, Nanoplastics and Heart Contamination: The Hidden Threat
This review examines growing evidence that micro- and nanoplastics can accumulate in human cardiovascular tissues, including blood, heart muscle, and arterial plaques. Researchers found that these particles may contribute to heart and blood vessel problems through inflammation, oxidative stress, blood clotting, and direct tissue injury. The study identifies plastic particles as a potential new environmental risk factor for cardiovascular health.
Emerging cardiovascular risks of micro- and nanoplastics: toxic effects and mechanistic pathways
Tiny plastic particles called micro- and nanoplastics are getting into our bodies through food, air, and skin contact, and researchers have found them building up in people's hearts and blood vessels. This review of existing studies shows these plastic bits may contribute to heart disease by causing inflammation and damaging cells in the cardiovascular system. While more research is needed, this suggests that plastic pollution isn't just an environmental problem—it could be directly harming our heart health.
Microplastics induce mitochondrial dysfunction and accelerate cardiovascular pathogenesis
Researchers reviewed evidence that micro- and nanoplastics detected in human cardiovascular tissues may contribute to cardiovascular disease through mitochondrial dysfunction. The study found that these particles can impair mitochondrial integrity, induce oxidative stress, disrupt calcium signaling, and promote genomic instability, suggesting a mechanistic link between plastic particle exposure and cardiovascular pathology.
Microplastics and nanoplastics: emerging threats to cardiovascular health – a comprehensive review
This comprehensive review examines the emerging evidence linking microplastic and nanoplastic exposure to cardiovascular health problems. The evidence suggests that plastic particles may contribute to heart and blood vessel disease, though more research is needed to fully understand the long-term effects. The review highlights the urgent need for further studies on how chronic exposure to these tiny particles affects the cardiovascular system.
Microplastics and Nanoplastics
Researchers examined the connection between microplastics and nanoplastics and cardiovascular disease, a group of conditions affecting the heart and blood vessels. Growing evidence suggests these tiny plastic particles may pose risks to heart and vascular health.
Micro-nanoplastic induced cardiovascular disease and dysfunction: a scoping review
Researchers reviewed evidence from animal and human studies on how micro- and nanoplastics (MNPs) affect the heart and blood vessels, finding that MNPs can damage the inner lining of blood vessels, promote plaque buildup, and interfere with blood clotting — all of which raise the risk of heart disease. The review calls for more research to understand how much MNP accumulation occurs in the human cardiovascular system and what it means for long-term cardiac health.
Micro-nanoplastic induced cardiovascular disease and dysfunction: a scoping review
This scoping review examined evidence linking micro- and nanoplastic exposure to cardiovascular disease and dysfunction, summarizing findings from animal and in vitro studies and identifying plausible mechanisms including inflammation and oxidative stress.
Microplastics as an Emerging Human Health Risk: Mechanisms, Exposure, and Clinical Evidence
This review examines the growing body of evidence on how microplastics enter the human body through ingestion, inhalation, and skin contact, and have now been detected in blood, lung tissue, placenta, and cardiovascular tissue. Evidence indicates that microplastics may cause harm through oxidative stress, inflammation, and cellular damage, though a direct causal link to specific health conditions has not yet been fully established.
Microplastics as an Emerging Human Health Risk: Mechanisms, Exposure, and Clinical Evidence
This review examines the growing body of evidence on how microplastics enter the human body through ingestion, inhalation, and skin contact, and have now been detected in blood, lung tissue, placenta, and cardiovascular tissue. Evidence indicates that microplastics may cause harm through oxidative stress, inflammation, and cellular damage, though a direct causal link to specific health conditions has not yet been fully established.
Tiny trouble: microplastics, nanoplastics, and their heartfelt impact on cardiovascular health
This review summarizes growing evidence that microplastics and nanoplastics have been found in human heart tissue, arterial plaques, and blood, and may increase the risk of cardiovascular disease. Lab studies show these particles can damage blood vessel walls, disrupt cholesterol processing, trigger inflammation, and promote blood clot formation, raising serious concerns about heart health.
Nanoplastics as emerging cardiovascular hazards: a narrative review of current evidence
This review examines the emerging evidence that nanoplastics may pose risks to cardiovascular health. Researchers summarized studies showing that nanoplastics can enter the bloodstream through ingestion, inhalation, and skin contact, potentially causing inflammation and oxidative damage to blood vessels and heart tissue. The study suggests that nanoplastic exposure represents an understudied but potentially significant environmental risk factor for heart and vascular problems.
Micro- and nanoplastics in the cardiovascular system: current evidence, research gaps: a systematic review
This systematic review examined how microplastics and nanoplastics affect the heart and blood vessels. Studies in both animals and human tissue found that these particles can cause blood vessel inflammation, disrupt heart function, and were even linked to higher rates of heart attack and stroke in people with plastic particles in their arteries.
Progress in Research on Microplastics and Nano-plastics Cardiac Toxicity
This review covers experimental and clinical evidence on the cardiovascular toxicity of microplastics and nanoplastics, documenting effects on heart function, vascular integrity, and inflammation pathways. It calls for more human clinical data to clarify the dose-response relationship and the relevance of laboratory findings to real-world cardiac risk.
Microplastics and nanoplastics in cardiovascular disease—a narrative review with worrying links
This review summarizes growing evidence linking micro- and nanoplastic exposure to cardiovascular disease, including increased blood pressure, blood vessel inflammation, and heart muscle damage observed in animal studies. Human population studies also show that people exposed to more plastics face higher rates of hypertension and heart attacks, though researchers are still working to understand the exact biological mechanisms involved.
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events
This landmark clinical study found that patients with micro- and nanoplastics detected in their carotid artery plaque had a significantly higher risk of heart attack, stroke, or death over a 34-month follow-up period compared to those without detectable plastics. This is one of the first studies to directly link microplastic presence in human blood vessels to worse cardiovascular outcomes. The findings suggest that plastic accumulation in arteries may be an important and previously unrecognized risk factor for heart disease.